Tonix Pharmaceuticals, Inc. (NASDAQ: TNXP) interview with Mr. Seth Lederman, CEO


Click the Subscribe button for the latest in crypto, blockchain and business news from NEW TO THE STREET!

See the full episode at:

Seth Lederman, CEO, Tonix Pharmaceuticals (NASDAQ: TNXP) talks to New To The Street TV once again about their Company’s pharmaceutical products, and his provides further discussion about their development and FDA phase 3 trials on its Fibromyalgia drug. Mr. Lederman talks about the importance of ‘HOW’ this Fibromyalgia drug helps patients sleep better without pain.

To make sure you never miss a video from New to the Street, click here to subscribe:

Follow New to the Street on Twitter:
Follow New to the Street on Facebook:
Follow New to the Street on Instagram:
About New to the Street:

Subscribe to our Mailing List: